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Abstract The goal of this randomized controlled study
was to investigate the effect of Heat and Moisture
Exchanger use on pulmonary symptoms and quality of life
aspects in laryngectomized patients. Eighty laryngecto-
mized patients were included and randomized into an HME
and Control group. The effect of the HME was evaluated
by means of Tally Sheets and Structured Questionnaires.
The results showed a signiﬁcant decrease in the frequency
of coughing, forced expectoration, and stoma cleaning in
the HME group. There were trends for the prosthetic
speakers to report more ﬂuent speech with the HME and
for the HME group to report fewer sleeping problems. In
conclusion, this study, performed in Poland, conﬁrms the
results of previous studies performed in other countries,
showing that pulmonary symptoms decrease signiﬁcantly
with HME use and that related aspects such as speech and
sleeping tend to improve, regardless of country or climate.
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Introduction
Knowledge concerning the inﬂuence of the upper respira-
tory tract on the physiology of the entire respiratory system
is well-documented [1–3]. Humidiﬁcation of inhaled air,
retention of a signiﬁcant amount of water from exhaled air,
balancing the optimal temperature of the air at the level of
the lower respiratory tract, and ﬁltration of inhaled air by
trapping dust particles and microorganisms on the surface
of the nasal mucosa, all support the defense mechanisms of
the respiratory system and are for a signiﬁcant part based
on the mucociliary clearance function.
After total laryngectomy, the upper and lower airways
are permanently disconnected and the patient breathes
through a permanent tracheostoma. During normal nasal
breathing, ambient air with a temperature of 22C and 40%
relative humidity (RH) is conditioned by the upper airways
and reaches a temperature up to 32C and RH up to 99% at
the level of the trachea, thereby creating an optimal con-
dition for the mucociliary clearance function of the tra-
cheobronchial tree. The air with the same parameters
inhaled through a tracheostoma reaches a temperature of
27–28C and 50% RH at a level of the trachea, which
signiﬁcantly reduces mucocilary clearance [1, 4]. The loss
of nasal function leads to impaired function of the cilia,
thickening and crusting of the mucous, irritation of the
mucosa of the tracheobronchial tree, and overproduction of
mucosal secretions. This, in turn leads to a wide range of
pulmonary complaints such as increased coughing and
forced expectoration, excessive sputum production, crust-
ing of the sputum and shortness of breath [5]. The symp-
toms increase during the ﬁrst 6–12 months after permanent
tracheostomy, and tend to stabilize later on [6]. The his-
tological changes of tracheobronchial mucosa include
squamous metaplasia of the ciliary epithelium and chronic
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membrane [7]. In laryngectomized patients, lower respi-
ratory tract infections signiﬁcantly increase, especially
during winter [5]. In normal individuals, clearing of the
lower airways from secretions takes place instinctively, and
with a minimal effort. This instinctive action in patients
with tracheostoma often requires forceful coughing and
subsequent cleaning of the stoma. These pulmonary
symptoms, together with the loss of the natural voice,
signiﬁcantly reduce quality of life of laryngectomized
patients [5, 8].
The use of Heat and Moisture Exchangers in laryngec-
tomized patients as a treatment option for the pulmonary
symptoms has become the gold standard of care in many
countries. Various studies have demonstrated the positive
effects of HME use on pulmonary function and tracheal
climate [9–17]. HME use has been found to signiﬁcantly
reduce coughing, forced expectoration, and stoma cleaning
and it has been found to have a positive effect on quality of
life [9–11, 13–15]. Application of an HME changes the
intratracheal temperature and humidity [16, 17]. With the
use of an HME, water loss due to tracheostoma breathing is
reduced from about 500 to 250–300 ml per day [18].
Only one of the clinical studies was randomized and
included a control group [10], but the HME used in that
study is not available anymore. In addition, this one ran-
domized controlled study was carried out in early postop-
erative period, while HMEs are often applied in long-term
laryngectomees as well. Thus, there is a need for random-
ized controlled studies that involve HMEs that are currently
available on the market in long-term laryngectomees.
Therefore, we conducted a randomized controlled study
on the effects of HME use in laryngectomized patients that
are in long-term follow up (longer than 6 months post
laryngectomy). The HME that was used in this study has
shown to be clinically effective in several prospective
studies in different countries and climates [12–15] and has
shown to have a positive effect on intratracheal tempera-
ture and humidity [16]. The study was carried out during
winter and in a group of patients that is representative of
the typical Polish laryngectomized patient, mostly repre-
senting a group with low socio-economic status.
Patients and methods
Patients
In total, 80 laryngectomized patients were entered into the
study and randomized for the HME (n = 40) or Control
(n = 40) group. The patients in the Control group were all
offered the option to try the HME system after the study
was ﬁnished.
The study took place from December 2007 to February
2008. The average temperature at that time in Poland
ranged from -1t o?2C (29–35 degrees Fahrenheit). The
age of the patients ranged from 38 to 80 years, with an
average of 62 years. The time since surgery varied from
10 months to 31.25 years, with an average of 5 years. Male
to female ratio was 68:12. Forty-nine patients had received
postoperative radiotherapy, 11 had received radiotherapy
as a primary treatment before salvage laryngectomy, and
20 patients had never received radiotherapy. Sixty-three
patients were married and 17 were living alone. The
majority of the participating patients were retired
(N = 70), eight were unemployed, and only two were full-
time employed. Forty-ﬁve patients had elementary/high-
school education level and 35 college or university. None
of the patients had used HME’s, foam pads or foam bibs
before the study. Sixty-one patients used tracheoesopha-
geal speech by means of a Provox
 voice prosthesis as
their main communication method, 14 used esophageal
speech, and 5 used ‘whispering’ (i.e. mouthing words
without sound production). In Table 1, the most important
patient characteristics are presented.
Methods
All patients were asked to record their daily number of
coughs and forced expectorations during the ﬁrst and the
last week of the study on a Tally Sheet. In addition to the
Tally Sheets, the patients completed structured question-
naires (adapted from the ones used in [10]) to report on
stoma cleaning, shortness of breath, fatigue, sleeping
problems, voice and speech, and psychological well-being.
The patients in the HME group completed an additional
Tally Sheet in the ﬁrst and last week that recorded the
amount of adhesives and HME cassettes that they used, and
they answered a structured questionnaire about their com-
pliance and experience with the HME system.
The HME System that was used in this study was the
Provox HME System (Atos Medical, Ho ¨rby, Sweden,
http://www.atosmedical.com). It contains porous foam
treated with calcium chloride and a lid to facilitate stoma
occlusion. The foam traps the heat and humidity from the
exhaled air and thereby conditions the inhaled air.
The clinical investigation was approved by the Ethical
Committee (National Oncology Center, Warsaw), and has
been conducted in accordance with International and
European Standard for Clinical Investigations (EN-ISO
14155-2:2003).
The primary outcome measures of the study were the
changes in coughing and forced expectorations as recorded
in the Tally Sheets. Factors that were considered when
evaluating the effect of the HME were age of the patient,
time since surgery, and compliance with the HME system.
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other factors that might possibly be affected by HME use.
Statistical analysis
The compliance data obtained from the HME users were
used to create two subgroups: one with fully compliant
users who used the device day and night and one with
reduced compliant users. The coughing and forced expec-
toration frequencies reported on the Tally Sheets were
analyzed using Splus (Version 6.2, Insightful Corp). The
expectation is that the frequencies will decrease with HME
use over time, and as such, the interaction between time
and HME use is included in the model. Two linear mixed
effects models were constructed (one for coughing and one
for forced expectorations) to examine the associations
between these two variables and HME use. Possible con-
founders (patient age and time since total laryngectomy)
were included in the models. The interaction with HME
use was also included for these two confounders since they
could possible inﬂuence the response of the patient to HME
use. To account for the skewed and clustered nature of the
data, we respectively took the square-root transform of the
outcome variables and used patient identiﬁer as a grouping
variable. All other analyses were carried out with SPSS
Version 15.0. Mean, standard deviations, and range were
computed for the reported frequencies of coughing, forced
expectoration, stoma cleaning, and adhesives and cassettes
used. Frequency Tabulations were made for all questions
separately. The separate questions regarding fatigue and
depression were Likert items and after being tested for
reliability by means of Cronbach’s alpha (a[0.70; see
[19]) they were summated into Likert scales that were used
for further reporting. Paired t tests were carried out to
compare the outcomes for the different aspects covered in
the questionnaires within the Control group, within the
HME group, and within the fully compliant and reduced
compliant HME group. When available the summated
Likert items were used for the tests. A P value below 0.05
was considered statistically signiﬁcant.
Results
Compliance
Four patients (10%) dropped out of the study (those
patients did not want to come in for the post-study ques-
tionnaire). Of those four patients, one patient was hospi-
talized for a recurrence, one could not use the HME due to
anxiety when his stoma was covered, and two could not use
the HME due to skin allergy/irritation from the adhesive.
Since they refused to come in to complete the post study
questionnaires, their results were excluded from analysis.
The remaining 36 patients had used the HME for
3 months. After a period of getting used to the HME, 25
Table 1 Patient characteristics
for all patients (n = 80) and the
Control and HME group
separately
Characteristic All patients Control group
(n = 40)
HME group
(n = 40)
Age
Range (years) 38–80 45–80 38–75
Average (years) 62 64 60
Post op follow up
Range 10 months–31 years 11 months–26 years 10 months–31 years
Average (years) 5 5 5.5
Gender
Male 68 38 30
Female 12 2 10
Radiotherapy
Primary 11 4 7
Post op 49 25 24
None 20 11 9
Speech method
Provox 61 31 30
Esophageal 14 4 10
‘Whispering’ 5 5 0
Stoma cover
Cloth bib 64 31 34
None 16 9 6
Eur Arch Otorhinolaryngol (2010) 267:429–435 431
123patients (70%) used the HME on a daily basis and 18 of
them used it day and night. Patients were asked whether
they used the HME never, sometimes, often, or always
during the day and during the night. Patients were con-
sidered compliant users when they used the HME day and
night. For practical reasons such as skin irritation, some
patients every now and then discontinued use of the HME
during the night. This was not considered non-compliance.
For further analysis, the patients were divided into a
compliant and a non-compliant subgroup.
Based on this ‘ideal compliance’ which was based on
the fact that normal individuals continuously enjoy the
beneﬁts of conditioning of the inhaled air by the upper
airways, 18 patients (50%) were considered fully compliant
and the other 18 (50%) were considered ‘reduced
compliant’.
Frequency of coughing and forced expectorations—
HME effect
All patients recorded their coughs and forced expectora-
tions during the ﬁrst week and the last week of the trial.
The results of the Tally Sheets show that the coughing
frequency in week 1 for all patients together averaged 52
(SD 41) and the frequency of forced expectorations aver-
aged 53 (SD 44). In Table 2, the frequencies for coughing
and forced expectorations in the ﬁrst and the last week, are
shown for the Control group, the ‘fully compliant’ HME
users and the ‘reduced compliant’ HME users.
As can be seen in Table 2, there is a slight reduction in
the average coughing and forced expectoration frequencies
in the control group, a larger reduction in the ‘reduced
compliance’ HME group, and a substantial reduction in the
‘full compliance’ HME group. As can be seen from the
standard deviations and ranges in this Table, the variation
among patients is large.
Two linear mixed effects models were constructed (one
for coughing and one for forced expectorations) to examine
the associations between these two variables and HME use.
The results of both models were similar. In both cases,
HME use causes a decrease in coughing and forced ex-
pectorations (P\0.001 in both cases). This decrease is
larger in patients with full HME compliance. Patients with
reduced HME compliance have a reduction; however, this
reduction is not signiﬁcantly different from the control
group. Older patients experienced more coughing and ex-
pectorations than younger patients (P = 0.02 for week 1
data, P = 0.0001 for week 12 data). In the aspect of
coughing and forced expectorations there was no signiﬁ-
cant difference between patients that were shorter, versus
longer after their surgery. There was no detectable asso-
ciation between the outcome variables and age and time
since total laryngectomy, indicating that the HME effect is
similar in older and younger patients and is not related to
the time of living with the tracheostoma.
Questionnaires
All 80 patients entered into the study completed the base-
line questionnaires. After 3 months, all patients, except the
four (all from the HME group), who dropped out, com-
pleted the same questions again.
Stoma cleaning
At baseline, patients reported to clean their stoma on
average 2.8 times per day (SD 1.8). Paired t tests between
the baseline and follow up data showed no signiﬁcant
changes in the Control group. In the HME group, the
number of times the stoma was cleaned per day decreased
signiﬁcantly [average 2.1 times per day (SD 1.2);
P = 0.001]. Paired t tests showed that this was signiﬁcant
both for the compliant group (P = 0.031) and the non-
compliant group (P = 0.013).
Shortness of breath
The patients were asked about shortness of breath while
climbing steps, walking, and while at rest. Both the HME
users and the control group experienced a decrease in
shortness of breath at rest. Paired t tests show that this is
signiﬁcant for both groups (HME group: P = 0.033;
Control Group: P = 0.006). The HME users experienced a
signiﬁcant increase in shortness of breath while climbing
steps P = 0.012). This is not unexpected, since the HME
causes an objective increase in breathing resistance that the
patient might experience during physical activity. Almost
60% of the patients indicated that they sometimes remove
the cassette when they experience increased resistance.
Table 2 Coughing and forced expectorations frequencies in week 1
and week 12 in different subgroups
Control HME
Reduced
compliance
Full compliance
Week 1 Week 12 Week 1 Week 12 Week 1 Week 12
Coughing frequency
Average 60 56 39 29 48 30
SD 41 37 27 22 48 21
Range 0–195 0–154 6–90 4–80 6–214 7–68
Forced expectorations
Average 59 53 37 28 56 27
SD 39 38 26 27 63 27
Range 7–177 7–189 10–110 2–101 0–284 0–98
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Fatigue was recorded on three Likert items that concerned
feeling the need to rest, feeling weak, and feeling tired
during the past week. Cronbach’s alpha was 0.905 at base-
line and 0.881 for the follow up data. Overall, most patients
(about 80%) reported no or only a little fatigue problems. A
paired t test did not show any differences in fatigue over
time between the Control and the total HME group or
between the full and reduced compliant HME users.
Sleeping problems
With regards to sleeping problems, the patients were asked
about waking up at night and the use of sleeping medica-
tion. In the control group, almost all patients (97.5%) had
sleeping problems and this did not change over time. In the
reduced compliant HME group, 89% of the patients had
this problem at baseline and it was the same 3 months later.
In the full compliance group, 79% of the patients had
sleeping problems at baseline and 72% had this problem
after 3 months. This reduction was not signiﬁcant, but
noteworthy: compliant use of an HME might reduce the
need to cough during the night and therefore reduce waking
up at night. At baseline, 27.5% of the patients in the control
group used sleeping pills and they still used those 3 months
later. In the HME group, 16.7% of the patients used
sleeping pills at baseline, and only 11% used sleeping pills
3 months later.
Voice and speech
The patients were asked to rate ﬁvedifferent aspects of their
speech (intelligibility, pitch, volume, ﬂuency, and intelli-
gibility over the phone), and overall voice quality. Paired t
tests did not show a signiﬁcant change in voice and speech
aspects over time in the Control or the HME group. The
HME group was analyzed in its entirety for the voice and
speech aspects, since compliance is not expected to inﬂu-
ence the aspects of speaking with the HME. Since not all
patients in our study used a voice prosthesis to speak and
since it is known that the HME contributes to maximum
phonation time and dynamic range in prosthetic speakers
[20], the group of patients (n = 61) using a voice prosthesis
was analyzed separately. Paired t tests on the voice and
speech aspects for the prosthetic speakers in the Control and
HME group, showed a trend for the prosthetic speakers to
report more ﬂuent speech with HME use (P = 0.073).
Psychological well being
The Likert scale for psychological well-being consisted of
four items: feeling tense, worried, irritable, and depressed
during the past week. Cronbach’s alpha was 0.813 at
baseline and 0.800 at follow up. Most patients (80–90%)
were reported no or only slight problems with anxiety and
depression at baseline. Paired t tests showed that feelings of
anxiety and depression had signiﬁcantly increased in the
Control group (P = 0.003), but in the HME groups no
signiﬁcant changes in the feelings of anxiety and depres-
sion could be found.
HME use
The usage of HME cassettes and adhesives decreased over
time. During the ﬁrst week of the study, on average 12.5
cassettes and 7.8 adhesives were used and during the last
week on average 9.5 HME cassettes and 6.1 adhesives
were used. The usage decreased for both products, as the
patients learned how to apply the adhesives and secretions
decreased. About half of the patients used a round shaped
adhesive and the other half an oval shaped one. Most
patients used a combination of various types of adhesives
(Regular, Flexiderm, Optiderm, XtraBase). Only one
patient used a LaryButton.
Table 3 shows the results that the HME users reported
about their experience with the HME system. The reasons
that patients gave for their problems with loosening or
leakage of the adhesive were that they had a deep stoma,
mucus was coming in between the adhesive and the skin, or
a combination of both.
Overall, all HME users were very positive about their
experience. All patients felt that they had beneﬁtted from
using the HME and all but one would use the HME if it
were prescribed by their physician and were covered by
insurance.
Discussion
When discussing pulmonary symptoms in laryngectomized
patients, one should keep in mind that most of them have
coexisting impairments of unspeciﬁed protective mecha-
nisms of the tracheo-bronchial tree, not only due to the loss
of nasal function, but also due to impaired pulmonary
function prior to the laryngectomy (i.e. most patients have
been long-term cigarette smokers). The mechanisms of an
unspeciﬁed protection of the tracheo-bronchal mucosa are
then chronically impaired, which is especially evident
during wintertime.
In our study, that was carried out during winter, fre-
quency of coughing and forced expectoration decreased
signiﬁcantly in patients who used the HME for 3 months.
This decrease was most signiﬁcant in patients who used the
HME day and night. The clinician plays an important role
in educating the patient about the importance of
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123compliance, and in supporting and advising the patient to
overcome problems that may reduce compliance such as
skin irritation and adhesion of the base plate. The impor-
tance of compliance has also been found in previous
studies [11, 13]. In our study, 70% of the patients used the
HME daily and 50% used it day and night, a similar out-
come was found in previous studies using the Provox HME
[13, 15]. The majority of laryngectomized patients in our
study did have a deep stoma since we did not routinely
perform additional surgical procedures during the total
laryngectomy to create a ﬂatter peristomal area. Some
patients reported this as a problem for getting a good seal
with the adhesive, but overall we did not record signiﬁcant
problems with adhering the baseplate to the skin. Appli-
cation of the adhesive requires some experience from the
patient, but after a short time, they become an expert in
their own particular case.
The structured questionnaires showed some changes in
stoma cleaning, ﬂuency of speech, waking up at night,
anxiety, and depression. However, the changes were not
as signiﬁcant as in previous studies. The frequency of
daily stoma cleaning, reﬂecting crusting and overproduc-
tion of mucosal secretions in the tracheobronchial tree,
reduced signiﬁcantly in the HME group. A trend showed
ﬂuency has improved in prosthetic speakers who use an
HME. This is in concordance with earlier ﬁndings [11].
About half of the patients found speaking with the HME
easier and all patients found stoma occlusion easier.
Problems with waking up at night reduced in the fully
compliant HME users, although not signiﬁcantly. The
results of our study with regard to the separate aspects of
voice and speech, sleeping, and depression are not as
evident as the results found by others. Compliant HME
users in our study reported a reduction in waking up at
night, but this was not signiﬁcant. Previous studies have
shown that seasonal ﬂuctuations in pulmonary symptoms
exist in laryngectomized patients [5, 21] and that pul-
monary symptoms tend to decrease further with longer
HME use and that psychosocial functioning tends to
improve over a longer period of time [6]. Perhaps the
pulmonary symptoms in the laryngectomized patients
during our study that was carried out in a cold climate
and during winter were quite severe at baseline and a
longer HME use might have revealed more signiﬁcant
improvements in related aspects such as sleep, fatigue,
depression and voice and speech. Interestingly, symptoms
of depression increased signiﬁcantly in the Control group
while they remained constant in the HME group. There is
no clear explanation for that, but it might be that patients
in general show more symptoms of depression during the
wintertime. This might have caused the increase of
depressive mood in the Control group, whereas it was
somehow prevented in the patients involved in the active
part of the study (HME group). One important aspect that
might also have caused the differences in results for the
structured questionnaires compared to previous studies
[10–15] is that we used Tally Sheets to record the fre-
quencies of coughing and forced expectorations. For
logistical reasons, we asked the patients to complete the
Tally Sheets during the ﬁrst and the last week of the
study. Thus, at baseline the questionnaire was completed
prior to the Tally Sheets and at follow up the order was
reversed. This might have caused a more negative outlook
at follow up. We recommend that in future studies the
Tally Sheets and structured questionnaires should be in
the same order at baseline and follow up.
Table 3 HME experience
Experience
Breathing
More difﬁcult 52%
Equal 17%
Less difﬁcult 31%
Removal of cassette when too high resistance is
experienced
58%
Speaking
More difﬁcult 19%
Equal 31%
Less difﬁcult 50%
Stoma occlusion
Quite good–very good 100%
Leakage of adhesive
Never 39%
Sometimes 57%
Often 4%
Removal of adhesive painful
Not–a little 94%
Quite painful 6%
Skin irritation
None–A little 77%
Quite a bit 17%
Very Much 6%
Loosening of adhesive
Not–A little 89%
Quite often 11%
Get used to HME
Average 3 to 4 days
Range 1 to
14 days
Beneﬁt from HME
Yes 100%
Use HME if reimbursed
Yes 97%
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The results of our randomized controlled study in long-
term Polish laryngectomized patients show that HME use
signiﬁcantly reduces pulmonary problems such as cough-
ing and forced expectorations. Compliance is crucial to
achieve this reduction in symptoms. There are some trends
showing that some quality of life aspects, like ﬂuency of
speech, ease of speech and stoma occlusion, sleeping, and
feelings of anxiety and depression are positively affected
by HME use.
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